What is he best known for?
The fields of study he is best known for:
His primary areas of investigation include Genetics, Genome-wide association study, Odds ratio, Glaucoma and Haplotype.
Allele, Genotype, Missense mutation, Mutation and Mutation are the primary areas of interest in his Genetics study.
His study looks at the intersection of Genome-wide association study and topics like Genetic association with Disease.
His Odds ratio research is multidisciplinary, incorporating perspectives in SNP and Case-control study.
His Glaucoma research is multidisciplinary, incorporating elements of Susceptibility locus and Optic nerve.
Khaled K. Abu-Amero works mostly in the field of Haplotype, limiting it down to topics relating to Risk factor and, in certain cases, Human genetics, Gene and Coronary artery disease.
His most cited work include:
- Mitochondrial abnormalities in patients with primary open-angle glaucoma. (222 citations)
- Genome-wide association analyses identify three new susceptibility loci for primary angle closure glaucoma (143 citations)
- Genome-wide association analyses identify three new susceptibility loci for primary angle closure glaucoma (143 citations)
What are the main themes of his work throughout his whole career to date?
Khaled K. Abu-Amero mainly investigates Genetics, Ophthalmology, Glaucoma, Internal medicine and Mitochondrial DNA.
His research ties Case-control study and Genetics together.
His study in the field of Open angle glaucoma, Intraocular pressure and Visual acuity also crosses realms of In patient.
His work deals with themes such as Odds ratio and Genome-wide association study, which intersect with Glaucoma.
His biological study deals with issues like Genotype, which deal with fields such as Risk factor and Coronary artery disease.
His Mitochondrial DNA research includes themes of Optic neuropathy, Optic nerve, Mitochondrion and Haplogroup.
He most often published in these fields:
- Genetics (41.49%)
- Ophthalmology (21.99%)
- Glaucoma (21.16%)
What were the highlights of his more recent work (between 2015-2021)?
- Ophthalmology (21.99%)
- Open angle glaucoma (16.18%)
- Genetics (41.49%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Ophthalmology, Open angle glaucoma, Genetics, Glaucoma and Genotype.
His study in Open angle glaucoma is interdisciplinary in nature, drawing from both Cohort and Risk factor.
His Genetics research incorporates elements of Odds ratio and Keratoconus.
His Odds ratio research integrates issues from Interquartile range and Case-control study.
His Glaucoma research includes themes of Systemic disease, Biomarker, Cytokine and Pathogenesis.
The Genotype study combines topics in areas such as Internal medicine and Intraocular pressure.
Between 2015 and 2021, his most popular works were:
- Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma. (84 citations)
- Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma. (84 citations)
- Resveratrol and Ophthalmic Diseases (64 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Mutation
- Internal medicine
Khaled K. Abu-Amero mainly focuses on Genome-wide association study, Odds ratio, Genetics, Human evolution and Phylogeography.
His work carried out in the field of Genome-wide association study brings together such families of science as Internal medicine, Case-control study, Disease and Glaucoma.
Khaled K. Abu-Amero has included themes like SNP, Interquartile range, Susceptibility locus and Genotype in his Glaucoma study.
His Odds ratio study frequently draws connections to other fields, such as Open angle glaucoma.
Genetics and Risk factor are frequently intertwined in his study.
As a part of the same scientific study, Khaled K. Abu-Amero usually deals with the Human evolution, concentrating on Mitochondrial DNA and frequently concerns with Haplogroup L3.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
